Lung Cancer Update

Follow Lung Cancer Update
Share on
Copy link to clipboard

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with…

Dr Neil Love


    • May 18, 2025 LATEST EPISODE
    • monthly NEW EPISODES
    • 53m AVG DURATION
    • 362 EPISODES


    More podcasts from Dr Neil Love

    Search for episodes from Lung Cancer Update with a specific topic:

    Latest episodes from Lung Cancer Update

    Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit

    Play Episode Listen Later May 18, 2025 50:15


    Clinical investigators discuss available data guiding the management of non-small cell lung cancer with immunotherapy and other nontargeted approaches.  CME information and select publications here.

    EGFR Mutation-Positive NSCLC — Fourth Annual National General Medical Oncology Summit

    Play Episode Listen Later Apr 30, 2025 52:17


    Clinical investigators discuss available data guiding the management of EGFR mutation-positive non-small cell lung cancer.  CME information and select publications here.

    Oncology Nursing Edition: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress

    Play Episode Listen Later Apr 26, 2025 93:02


    Dr Edward B Garon, Dr Tiffany A Traina, and nurse practitioners Ms Marianne J Davies and Ms Marissa Marti-Smith discuss the role of antibody-drug conjugates in the care of patients with breast and lung cancer and strategies to mitigate and manage treatment-emergent adverse events. NCPD information and select publications here.

    First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor

    Play Episode Listen Later Apr 10, 2025 57:28


    Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer. CME information and select publications here.

    EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

    Play Episode Listen Later Feb 6, 2025 60:02


    Dr Enriqueta Felip from the Vall d'Hebron Institute of Oncology in Barcelona, Spain, and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, discuss current and emerging treatment approaches for patients with EGFR-mutant non-small cell lung cancer. CME information and select publications here

    Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer

    Play Episode Listen Later Dec 13, 2024 48:03


    Dr Edward B Garon shares his perspectives on the evolving therapeutic landscape for patients with lung cancer.

    Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer

    Play Episode Listen Later Dec 11, 2024 58:47


    Dr Heather Wakelee from Stanford University School of Medicine in California discusses the implications of recent datasets for the current and future use of nontargeted therapy for metastatic non-small cell lung cancer.

    The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences

    Play Episode Listen Later Nov 25, 2024 60:11


    Dr Suresh S Ramalingam from the Emory University School of Medicine in Atlanta, Georgia and Dr Gregory J Riely from Memorial Sloan Kettering Cancer Center in New York, New York discuss the implications of recent data sets for the current and future management of lung cancer.

    Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Lung Cancer

    Play Episode Listen Later Nov 16, 2024 65:42


    Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with lung cancer.

    Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences

    Play Episode Listen Later Nov 7, 2024 54:39


    Dr Stephen V Liu from Georgetown University Hospital in Washington, DC, reviews recently presented data with and newly approved therapies for localized and advanced lung cancers.

    The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

    Play Episode Listen Later Oct 23, 2024 42:46


    Dr Jacob Sands from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent presentations on approved and investigational therapies in small cell lung cancer from the 2024 World Conference on Lung Cancer.

    The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer

    Play Episode Listen Later Oct 16, 2024 60:07


    Dr Edward Garon from UCLA Health Jonsson Comprehensive Cancer Center and Dr Luis Paz-Ares from the Spanish National Oncology Research Center in Madrid share their perspectives on recent datasets from the 2024 World Conference on Lung Cancer on the management of non-small cell lung cancer without actionable genomic alterations.

    The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR

    Play Episode Listen Later Oct 8, 2024 58:13


    Dr Ibiayi Dagogo-Jack from Massachusetts General Hospital in Boston and Dr Corey J Langer from the Abramson Cancer Center in Philadelphia, Pennsylvania, discuss the implications of recent datasets for the current and future management of non-small cell lung cancer with actionable targets beyond EGFR.

    The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations

    Play Episode Listen Later Oct 2, 2024 58:19


    Dr Joshua K Sabari from the NYU Langone Health Perlmutter Cancer Center and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landscape for non-small cell lung cancer with EGFR mutations.

    Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors

    Play Episode Listen Later Sep 19, 2024 59:19


    Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors.

    Striving for Consensus: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation

    Play Episode Listen Later Sep 12, 2024 123:22


    Dr Pasi Jänne from the Dana-Farber Cancer Institute in Boston, Massachusetts, Prof Tom John from the Peter MacCallum Cancer Centre in Melbourne, Australia, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, Massachusetts, and Dr Alexander Spira from the Virginia Cancer Specialists Research Program in Fairfax, discuss recent updates on available and emerging treatment strategies for non-small cell lung cancer with an EGFR mutation.

    Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer

    Play Episode Listen Later Aug 21, 2024 61:23


    Prof Solange Peters from the Lausanne University Hospital in Lausanne, Switzerland, and Professor Ben Solomon from the Peter MacCallum Cancer Centre in Melbourne, Australia, discuss treatment approaches for ALK-rearranged non-small cell lung cancer in the localized disease setting.

    Oncology Today with Dr Neil Love: Novel Agents and Strategies in Lung Cancer

    Play Episode Listen Later Aug 14, 2024 61:43


    Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Ticiana Leal from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Manish Patel from Florida Cancer Specialists & Research Institute in Sarasota, Florida, summarize recently presented advancements, including novel strategies, in the treatment of lung cancer.

    Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer

    Play Episode Listen Later Aug 5, 2024 60:53


    Dr Matthew Gubens from the University of California, San Francisco summarizes important 2023 datasets guiding the use of immunotherapy and other nontargeted approaches for patients with NSCLC and no actionable mutations.

    Oncology Today with Dr Neil Love: An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation

    Play Episode Listen Later Jul 25, 2024 47:34


    Dr Jonathan W Goldman from UCLA Health in Santa Monica, California summarizes recent developments presented at ASCO 2024 for patients with non-small cell lung cancer with an EGFR mutation.

    Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer

    Play Episode Listen Later Jun 12, 2024 60:48


    Dr Justin F Gainor from Massachusetts General Hospital in Boston and Dr Karen Reckamp from Cedars-Sinai Center in Los Angeles, California, summarize recently presented data on targeted therapy strategies for non-small cell lung cancer harboring actionable therapeutic targets.

    Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates

    Play Episode Listen Later Apr 4, 2024 32:24


    Dr Manish Patel from the Florida Cancer Specialists & Research Institute in Sarasota, Florida, discusses drug development, early-phase clinical trials and the emerging field of B7-H3-targeted antibody-drug conjugates for solid tumors.

    Oncology Today with Dr Neil Love: Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer

    Play Episode Listen Later Mar 20, 2024 62:57


    Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, discusses available data with antibody-drug conjugates with established and investigational targets in patients with non-small cell lung cancer.

    Implications of Recent Data Sets for the Current and Future Management of Lung Cancer

    Play Episode Listen Later Dec 11, 2023 90:16


    Dr Luis Paz-Ares from the National Oncology Research Center in Madrid, Spain, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, and Dr David R Spigel from the Sarah Cannon Research Institute in Nashville, Tennessee, discuss key presentations from the 2023 ESMO Congress for the management of lung cancer.

    Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer

    Play Episode Listen Later Oct 16, 2023 61:39


    Dr Jamie Chaft and Dr John Heymach discuss the optimal integration of targeted therapy and immunotherapy into the care of patients with localized non-small cell lung cancer.

    Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy

    Play Episode Listen Later Sep 8, 2023 163:37


    Dr Corey Langer, Dr Ticiana Leal, Dr Karen Reckamp and Dr Jacob Sands discuss the optimal current management of relapsed NSCLC and provide perspectives on the future of care for patients with this disease.

    Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

    Play Episode Listen Later Aug 22, 2023 32:15


    Featuring a discussion on key presentations on lung cancer from the 2023 ASCO Annual Meeting, with Dr Matthew Gubens, moderated by Dr Neil Love.

    Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer

    Play Episode Listen Later May 1, 2023 63:19


    Proceedings from our Year in Review webinar on immunotherapy and other nontargeted approaches for lung cancer. Featuring perspectives from Drs Luis Paz-Ares and Heather Wakelee, moderated by Dr Neil Love.

    Recent Advances and Future Directions in Lung Cancer — With Dr Ibiayi Dagogo-Jack and Stephen Liu (Proceedings from a Symposium in Partnership with NCOA and SCOS)

    Play Episode Listen Later Mar 17, 2023 59:04


    Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, chronic lymphocytic leukemia and lymphomas, gynecologic cancers and lung cancer. Featuring perspectives from Drs Tanios Bekaii-Saab, Michael Birrer, Danielle Brander, Harold Burstein, Ibiayi Dagogo-Jack, Virginia Kaklamani, Stephen Liu, Ursula Matulonis, Rutika Mehta, Craig Moskowitz, Daniel Petrylak and Sandy Srinivas.

    partnership symposium proceedings lung cancer future directions recent advances virginia kaklamani ursula matulonis daniel petrylak ibiayi dagogo jack harold burstein rutika mehta south carolina oncology society
    Striving for Consensus on the Management of ALK-Positive Lung Cancer

    Play Episode Listen Later Mar 6, 2023 149:53


    Featuring a discussion on the management of ALK-positive lung cancer with Dr Ross Camidge, Dr Justin Gainor, Prof Solange Peters and Prof Ben Solomon, moderated by Dr Neil Love.

    Oncology Today with Dr Neil Love: Management of HER2-Altered Non-Small Cell Lung Cancer?

    Play Episode Listen Later Feb 21, 2023 80:06


    Featuring a discussion on targeted therapy for HER2-altered non-small cell lung cancer with Dr Bob Li, moderated by Dr Neil Love.

    Oncology Today with Dr Neil Love: Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation

    Play Episode Listen Later Feb 13, 2023 49:37


    Featuring a discussion on new and emerging data in the management of NSCLC without an actionable mutation, with Dr Edward Garon, moderated by Dr Neil Love.

    Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer

    Play Episode Listen Later Jan 24, 2023 60:16


    Proceedings from our Year in Review webinar on targeted therapy for non-small cell lung cancer. Featuring perspectives from Drs Zofia Piotrowska and Gregory Riely, moderated by Dr Neil Love.

    Can the Compelling Power of Virtual Education Assist in Reducing Cancer Care Disparities, Particularly in Clinical Trial Participation?

    Play Episode Listen Later Dec 29, 2022 60:53


    Featuring perspectives from Drs Shaachi Gupta, Zanetta Lamar and Estelamari Rodriguez, moderated by Dr Neil Love.

    Emerging Role of Antibody‑Drug Conjugates in the Management of Non‑Small Cell Lung Cancer

    Play Episode Listen Later Dec 16, 2022 60:12


    Featuring discussion on non-small cell lung cancer with Drs Alexander Spira and Helena Yu, moderated by Dr Neil Love.

    Oncology Today with Dr Neil Love: Thyroid Cancer

    Play Episode Listen Later Dec 8, 2022 69:07


    Featuring a discussion on recent advances in the treatment of thyroid cancer with Dr Eric Sherman, moderated by Dr Neil Love.

    Current Paradigm and Future Directions for Immunotherapy in the Treatment of Metastatic Non-Small Cell Lung Cancer

    Play Episode Listen Later Nov 28, 2022 64:08


    Featuring a discussion on the use of immunotherapy in the treatment of metastatic non-small cell lung cancer with Drs John Heymach and Sephen Liu, moderated by Dr Neil Love.

    The Clinical Implications of Key Recent Data Sets in Lung Cancer — With Drs Corey Langer and Christine Lovly (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)

    Play Episode Listen Later Nov 16, 2022 61:27


    Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in lung cancer. Featuring perspectives from Drs Corey Langer and Christine Lovly, moderated by Dr Neil Love.

    Oncology Today with Dr Neil Love: Management of MET-Altered Non-Small Cell Lung Cancer

    Play Episode Listen Later Nov 7, 2022 39:12


    Featuring a discussion on recent advances in the treatment of non-small cell lung cancer harboring MET alteration with Dr Rebecca Heist, moderated by Dr Neil Love.

    Oncology Today with Dr Neil Love: Neuroendocrine Tumors

    Play Episode Listen Later Nov 1, 2022 38:21


    Featuring a discussion on recent advances in understanding and treating neuroendocrine tumors with Dr Pamela Kunz, moderated by Dr Neil Love.

    Meet The Professor: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation — Part 3 of a 3-Part Series

    Play Episode Listen Later Oct 31, 2022 62:14


    Featuring a discussion on the treatment of non-small cell lung cancer with Dr Pasi Jänne, moderated by Dr Neil Love.

    Oncology Today with Dr Neil Love: Management of RET Fusion-Positive Non-Small Cell Lung Cancer

    Play Episode Listen Later Oct 25, 2022 46:30


    Featuring a discussion on recent advances in the care of patients with RET-rearranged non-small cell lung cancer with Dr Justin Gainor, moderated by Dr Neil Love.

    Claim Lung Cancer Update

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel